NCT02999711View on ClinicalTrials.gov

Study of Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of REGN3500 in Adults With Moderate Asthma

PHASE1CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

February 3, 2017

Primary Completion Date

August 30, 2018

Study Completion Date

September 10, 2018

Conditions
AsthmaModerate Asthma
Interventions
DRUG

REGN3500

REGN3500 dose

DRUG

Placebo

Matching placebo

Trial Locations (3)

Unknown

Regeneron Research Site, Belfast

Regeneron Research Site, London

Regeneron Research Site, Manchester

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Regeneron Pharmaceuticals

INDUSTRY